title: Quality of pediatric second-degree burn wound scars following the application of basic fibroblast growth factor: results of a randomized, controlled pilot study ﻿.
abstract: ﻿﻿﻿﻿﻿﻿﻿﻿﻿﻿﻿﻿﻿﻿﻿﻿Pediatric burn wounds present unique challenges. Second-degree burns may increase in size and depth, raising concerns about healing and long-term scarring. Results of a clinical study in adults with second-degree burn wounds suggest that application of basic fibroblast growth factor (bFGF) may reduce time to second-intention healing and result in a more cosmetically acceptable scar. To evaluate the effect of this treatment on pediatric patients with deep second- degree burn wounds, 20 pediatric patients ranging in age from 8 months to 3 years (average 1 year, 3 months [± 6 months]) with a total of 30 burn wounds from various causes were allocated either the growth factor (treatment, n = 15) or an impregnated gauze treatment (control, n = 15). Wounds still exudative (not healed) after 21 days were covered with a split-thickness skin graft. All wounds were clinically assessed until healed and after 1 year. A moisture meter was used to assess scars of wounds healing by secondary intention. A color meter was used to evaluate grafted wounds. Five wounds in each group required grafting. Skin/scar color match was significantly closer to 100% in the treatment than in the control group (P <0.01). Wounds not requiring grafting were no longer exudative after 13.8 (± 2.4) and 17.5 (± 3.1) days in the treatment (n = 10) and control group (n = 10), respectively (P <0.01). After 1 year, scar pigmentation, pliability, height, and vascularity were also significantly different (P <0.01) between the groups. Hypertrophic scars developed in 0 of 10 wounds in the treatment and in three of 10 wounds in the control group, and effective contact coefficient, transepidermal water loss, water content, and scar thickness were significantly greater in control group (P <0.01). Both the short- and long-term results of this treatment in pediatric burn patients are encouraging and warrant further research.
authors.affiliation: Department of Plastic and Reconstructive Surgery, National Nagasaki Medical Center, Nagasaki University Graduate School of Biomedical Science, Japan.
authors.forename: Kenji
authors.initials: K
authors.lastname: Hayashida
authors.forename: Sadanori
authors.initials: S
authors.lastname: Akita
mesh_terms: D002056:Burns / Q000150:complications*; D002648:Child; D002921:Cicatrix / Q000188:drug therapy* / Q000209:etiology; D016222:Fibroblast Growth Factor 2 / Q000627:therapeutic use*; D006801:Humans; D010865:Pilot Projects; D011994:Recombinant Proteins / Q000627:therapeutic use; D014945:Wound Healing
chemical_list: D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2